blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2546250

EP2546250 - Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  22.04.2016
Database last updated on 05.10.2024
Most recent event   Tooltip22.04.2016Application deemed to be withdrawnpublished on 25.05.2016  [2016/21]
Applicant(s)For all designated states
Abbott GmbH & Co. KG
Max-Planck-Ring 2
65205 Wiesbaden / DE
[2013/03]
Inventor(s)01 / Lubisch, Wilfried
Hirtenaue 38
69118 Heidelberg / DE
02 / Hornberger, Wilfried
Goldener Winkel 14
67434 Neustadt / DE
03 / Oost, Thorsten K.
Baind 24
88400 Biberach an der Riss / DE
04 / Sauer, Daryl Richard
23619 112th Street
Trevor, WI Wisconsin 53179 / US
05 / Unger, Liliane
Wollstr. 129
67065 Ludwigshafen / DE
06 / Wernet, Wolfgang
Freiheitstr. 73
67434 Neustadt / DE
07 / Geneste, Hervé
Rehbachstr. 42
67141 Neuhofen / DE
 [2013/03]
Representative(s)Reitstötter Kinzebach
Patentanwälte
Im Zollhof 1
67061 Ludwigshafen / DE
[N/P]
Former [2013/03]Reitstötter - Kinzebach
Patentanwälte Ludwigsplatz 4
67059 Ludwigshafen / DE
Application number, filing date12177640.530.09.2004
[2013/03]
Priority number, dateUS2003067530030.09.2003         Original published format: US 675300
[2013/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2546250
Date:16.01.2013
Language:EN
[2013/03]
Search report(s)(Supplementary) European search report - dispatched on:EP19.12.2012
ClassificationIPC:C07D401/14, C07D409/04, C07D417/14, C07D413/14, A61K31/404, A61P25/00
[2013/03]
CPC:
C07D401/14 (EP,US); A61P1/14 (EP); A61P25/00 (EP);
A61P25/04 (EP); A61P25/18 (EP); A61P25/20 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P25/30 (EP); A61P25/32 (EP); A61P43/00 (EP);
A61P5/06 (EP); A61P5/38 (EP); C07D401/12 (EP,US);
C07D403/14 (EP,US); C07D405/14 (EP,US); C07D409/04 (EP,US);
C07D409/14 (EP,US); C07D413/14 (EP,US); C07D417/14 (EP,US);
C07D513/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2013/03]
Extension statesALNot yet paid
HR12.07.2013
LT12.07.2013
LV12.07.2013
MKNot yet paid
TitleGerman:Heteroarylsubstituierte 1,3-Dihydroindol-2-onderivate und diese enthaltende Medikamente[2013/03]
English:Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them[2013/03]
French:Derives heteroaryle-substitues de 1,3-dihydroindol-2-one et medicaments renfermant ceux-ci[2013/03]
Examination procedure12.07.2013Amendment by applicant (claims and/or description)
12.07.2013Examination requested  [2013/34]
27.08.2013Despatch of a communication from the examining division (Time limit: M06)
03.03.2014Reply to a communication from the examining division
24.07.2015Despatch of a communication from the examining division (Time limit: M04)
05.12.2015Application deemed to be withdrawn, date of legal effect  [2016/21]
14.01.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2016/21]
Parent application(s)   TooltipEP04765719.2  / EP1667993
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040765719) is  19.07.2010
Fees paidRenewal fee
21.11.2012Renewal fee patent year 03
21.11.2012Renewal fee patent year 04
21.11.2012Renewal fee patent year 05
21.11.2012Renewal fee patent year 06
21.11.2012Renewal fee patent year 07
21.11.2012Renewal fee patent year 08
26.09.2012Renewal fee patent year 09
09.09.2013Renewal fee patent year 10
08.09.2014Renewal fee patent year 11
08.09.2015Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]WO9315051  (SANOFI ELF [FR]) [YD] 1-16* example -; table 3 *;
 [YD]WO9518105  (SANOFI SA [FR], et al) [YD] 1-16 * example -; tables II,III,IV *;
 [Y]WO03008407  (SANOFI SYNTHELABO [FR], et al) [Y] 1-16 * example -; table 2 *
by applicantWO9315051
 WO9518105
 WO9825901
    - GRIEBEL ET AL., PNAS, (2002), vol. 99, page 6370
    - SERRADEIL-LE GAL ET AL., J. PHARM. EXP. THER., (2002), vol. 300, page 1122
    - The Practice of Medicinal Chemistry, ACADEMIC PRESS, (1996), pages 671 - 715
    - Fortschritte der Arzneimittelforschung, BIRKHäUSER VERLAG, (1966), vol. 10, pages 224 - 285
    - TAHARA A ET AL., BRIT. J. PHARMACOL., (1998), vol. 125, pages 1463 - 1470
    - MUNSON PJ; RODBARD D, ANALYTICAL BIOCHEM, (1980), vol. 107, pages 220 - 239
    - PORSOLT RD; LEPICHON M; JALFRE M, "Depression: a new animal model sensitive to antidepressant treatment", NATURE, (1977), vol. 266, pages 730 - 732
    - "Pharmacological models of depression", PORSOLT RD; LENEGRE A; MCARTHUR RA, Animal models in Psychopharmacology, BIRKHAUSER VERLAG, (1991), pages 137 - 159
    - PORSOLT RD; ANTON G; BLAVET N; JALFRE M., "Behavioural despair in rats: a new model sensitive to antidepressant treatments", EUROPEAN JOURNAL OF PHARMACOLOGY, (1978), vol. 47, doi:doi:10.1016/0014-2999(78)90118-8, pages 379 - 391, XP025547160

DOI:   http://dx.doi.org/10.1016/0014-2999(78)90118-8
    - A.R. KATRITZKY; A.J. BOULTON, Advances in Heterocyclic Chemistry, ACADEMIC PRESS, (1975), vol. 18, pages 2 - 58
    - J. BRAZIL. CHEM. SOC., (2001), vol. 12, pages 273 - 324
    - G. QUEGUINER ET AL., Advances in Heterocyclic Chemistry, ACADEMIC PRESS, (1991), vol. 52, pages 187 - 304
    - J. HETEROCYCLIC CHEM., (2000), vol. 37, page 615
    - HETEROCYLES, (1994), vol. 37, page 2149
    - J. MED. CHEM., (1997), vol. 40, page 1149
    - J. MARCH, Advanced Organic Chemistry, WILEY, (1992), page 724
    - TETRAHEDRON LETT., (1993), vol. 34, page 5287
    - BIOORG. MED. CHEM. LETT., (2001), vol. 11, page 2213
    - J. MARCH, Advanced Organic Chemistry, WILEY, (1992), pages 417 - 421,499,
    - J. MED. CHEM., (2000), vol. 43, page 2087
    - J. MARCH, Advanced Organic Chemistry, WILEY, (1992), page 411
    - J. MARCH, Advanced Organic Chemistry, WILEY, (1992), pages 417 - 421
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.